The current status of autologous blood transfusion in Japan - The importance of pre-deposit autologous blood donation program and the needs to achieve patient blood management

Transfusion and Apheresis Science

Volumn 49, Issue 3, 2013, Pages 673-680

  Tsuno, Nelson Hirokazu ^a   Nagura, Yutaka ^a   Kawabata, Michiru ^a   Matsuhashi, Mika ^a   Sone, Shinji ^a   Ikeda, Toshiyuki ^a   Okochi, Naoko ^a   Takahashi, Koki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Autologous blood transfusion; Patient blood management; Pre deposit autologous blood donation program

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD GROUP TYPING; COST EFFECTIVENESS ANALYSIS; CRYOPRECIPITATE; ELECTIVE SURGERY; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT;

AUTOLOGOUS BLOOD TRANSFUSION; PATIENT BLOOD MANAGEMENT; PRE-DEPOSIT AUTOLOGOUS BLOOD DONATION PROGRAM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD DONORS; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84888440716     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2013.02.002     Document Type: Article

References (29)

1. Ferraris V.A., Brown J.R., Despotis G.J., Hammon J.W., Reece T.B., Saha S.P., et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011, 91:944-982.
2. Huet C., Salmi L.R., Fergusson D., Koopman-van Gemert A.W., Rubens F., Laupacis A. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg 1999, 89:861-869.
3. Moskowitz D.M., Klein J.J., Shander A., Cousineau K.M., Goldweit R.S., Bodian C., et al. Predictors of transfusion requirements for cardiac surgical procedures at a blood conservation center. Ann Thorac Surg 2004, 77:626-634.
4. Moskowitz D.M., McCullough J.N., Shander A., Klein J.J., Bodian C.A., Goldweit R.S., et al. The impact of blood conservation on outcomes in cardiac surgery: is it safe and effective?. Ann Thorac Surg 2010, 90:451-458.
5. Nalla B.P., Freedman J., Hare G.M., Mazer C.D. Update on blood conservation for cardiac surgery. J Cardiothor Vasc Anesth 2012, 26:117-133.
6. Spahn D.R. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 2010, 113:482-495.
7. Wang G., Bainbridge D., Martin J., Cheng D. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg 2009, 109:320-330.
8. Shander A., Van Aken H., Colomina M.J., Gombotz H., Hofmann A., Krauspe R., et al. Patient blood management in Europe. Brit J Anaesth 2012, 109:55-68.
9. Vanderlinde E.S., Heal J.M., Blumberg N. Autologous transfusion. BMJ 2002, 324:772-775.
10. Tasaki T., Gotoh K., Fujii K., Sasaki S., Satoh S., Takadate J., et al. Accumulated cytokines in stored autologous blood do not cause febrile nonhemolytic transfusion reactions. Transfus Apher Sci 2008, 39:15-19.
11. Uhlmann E.J., Isgriggs E., Wallhermfechtel M., Goodnough L.T. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Transfusion 2001, 41:997-1000.
12. Vamvakas E.C. Meta-analysis of randomized controlled trials comparing the risk of postoperative infection between recipients of allogeneic and autologous blood transfusion. Vox Sang 2002, 83:339-346.
13. Vamvakas E.C., Blajchman M.A. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007, 21:327-348.
14. Uhl L. Patient blood management: a 68-year-old woman contemplating autologous blood donation before elective surgery. JAMA 2011, 306:1902-1910.
15. Gombotz H. Patient blood management: a patient-orientated approach to blood replacement with the goal of reducing anemia, blood loss and the need for blood transfusion in elective surgery. Transfus Med Hemother 2012, 39:67-72.
16. Moonen A.F., Neal T.D., Pilot P. Peri-operative blood management in elective orthopaedic surgery. A critical review of the literature. Injury 2006, 37(Suppl. 5):S11-S16.
17. Green W.S., Toy P., Bozic K.J. Cost minimization analysis of preoperative erythropoietin vs. autologous and allogeneic blood donation in total joint arthroplasty. J Arthroplasty 2010, 25:93-96.
18. Etchason J., Petz L., Keeler E., Calhoun L., Kleinman S., Snider C., et al. The cost effectiveness of preoperative autologous blood donations. New Engl J Med 1995, 332:719-724.
19. Birkmeyer J.D., Goodnough L.T., AuBuchon J.P., Noordsij P.G., Littenberg B. The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion 1993, 33:544-551.
20. Billote D.B., Glisson S.N., Green D., Wixson R.L. A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am 2002, 84-A:1299-1304.
21. Regis D., Corallo F., Franchini M., Rosa R., Ricci M., Bartolozzi P. Preoperative autologous blood donation in primary total knee arthroplasty: critical review of current indications. Chir Organi Mov 2008, 91:41-44.
22. Bouchard D., Marcheix B., Al-Shamary S., Vanden Eynden F., Demers P., Robitaille D., et al. Preoperative autologous blood donation reduces the need for allogeneic blood products: a prospective randomized study. Can J Surg 2008, 51:422-427.
23. Joy P.J., Bennet S.J. The appropriateness of blood transfusion following primary total hip replacement. Ann Roy Coll Surg Engl 2012, 94:201-203.
24. Spencer J., Thomas S.R., Yardy G., Mukundan C., Barrington R. Are we overusing blood transfusing after elective joint replacement? - a simple method to reduce the use of a scarce resource. Ann Roy Coll Surg Engl 2005, 87:28-30.
25. Heneghan C., Perera R. Prevention of hepatitis C in Japan: a lesson for us all. Lancet 2007, 370:1982-1983.
26. McCurry J. Japan compensates some of its hepatitis C victims. Lancet 2008, 371:1061-1062.
27. Yasunaga H. Risk of authoritarianism: fibrinogen-transmitted hepatitis C in Japan. Lancet 2007, 370:2063-2067.
28. Takahashi K. The new Blood Law and new principles of transfusion therapy. Nihon Geka Gakkai Zasshi 2005, 106:3-6.
29. Takahashi K. New guideline for transfusion medicine. Rinsho Byori 2006, 54:1234-1240.